//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 12 August, 2020, 12:10 PM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Biocon Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 12 Aug, 2020, 12:12 PM IST
    397.10

    Today's Change

    -10.45 (-2.56%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    2,303,761

    Open

    407.55

    Prev. Close

    407.55

    Day's Trend

    Low
    396.50
    High
    407.80
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)5.00
    • EPS-TTM (Rs.)5.76
    • BV/share (₹)61.53
    • 52Wk L/H211.05/ 446.95
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News

    Biocon Ltd Stock Price F & O Quotes

    Hold Biocon, target price Rs 410: Anand Rathi| Recos
    Hold
    Buy Biocon, target price Rs 390: Geojit| Recos
    Buy
    Reduce Biocon, target price Rs 250: Edelweiss| Recos
    Reduce
    Neutral on Biocon, target price Rs 305: Motilal Oswal| Recos
    Neutral
    Neutral on Biocon, target price Rs 320: Motilal Oswal| Recos
    Buy
    Buy Biocon, target price Rs 350: Edelweiss| Recos
    Buy
    Citigroup has buy on Biocon, target price Rs 360| Recos
    Buy
    Sell Biocon, price target Rs 290: CK Narayan| Recos
    Sell
    Buy Biocon, price target Rs 325: Manas Jaiswal| Recos
    Buy
    Buy Biocon, price target Rs 325: Kunal Bothra| Recos
    Buy
    Buy Biocon, price target Rs 325: Kunal Bothra| Recos
    Buy
    Buy Biocon, price target Rs 330: Mandar Jamsandekar| Recos
    Buy
    Buy Biocon, price target Rs 320: CK Narayan| Recos
    Buy
    Buy Biocon, price target Rs 330: Manas Jaiswal| Recos
    Buy
    CLSA maintains sell on Biocon, target price Rs 220| Recos
    Sell
    Buy Biocon, price target Rs 300: CK Narayan| Recos
    Buy
    Buy Biocon, price target Rs 311: Jay Thakkar| Recos
    Buy
    Buy Biocon, price target Rs 317: Chandan Taparia| Recos
    Buy
    Sell Biocon, target Rs 270: Kunal Bothra| Recos
    Sell
    Citigroup has buy on Biocon, target price Rs 350| Recos
    Buy
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    Biocon Ltd. shares rise 2.58% as Sensex climbs| News
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    Biocon Ltd.Execution Of SHA And SSA With Tata Capital Growth Fund II - Disclosure Pursuant To Regulation 30 Of SEBI Regulations, 20...| Announcement
    Biocon Ltd. shares up 1.7% as Nifty gains| News
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Biocon Ltd. shares gain 1.1% as Sensex rises| News
    Biocon Ltd. shares rise 0.13% as Sensex climbs| News
    Biocon Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Biocon Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    Biocon Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Biocon Ltd.Financial Results For The Quarter Ended June 30, 2020.| Announcement
    Biocon Ltd.Financial Results For The Quarter Ended June 30, 2020| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Biocon Ltd.Statement Of Investor Complaints For The Quarter Ended June 2020| Announcement
    Biocon Ltd.Shareholding for the Period Ended June 30, 2020| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Biocon Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Biocon Ltd.Board Meeting Intimation for Board Meeting And Trading Window Closure| Announcement
    Biocon Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Biocon Ltd.Reg. 34 (1) Annual Report| Announcement

    Biocon Ltd. Share Price Updates

    Biocon Ltd. share price down by -2.31% from its previous close of Rs 407.55. Biocon Ltd. stock last traded price is 398.15
    Biocon Ltd. Share Price
    Value
    Today/Current/Last
    398.15
    Previous Day
    407.55
    What's your view on Biocon for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Biocon Ltd.

    Biocon Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    1,671.30
    5.71
    14.01
    1.43
    7585.25
    Other Operating Income
    0.00
    0.00
    0.00
    0.00
    118.06
    Operating Profit
    413.30
    29.72
    -5.53
    -14.20
    2526.83
    Other Income
    18.30
    -71.00
    -24.07
    0.13
    153.79
    EBITDA
    431.60
    13.07
    -6.50
    -14.20
    2526.83
    Interest
    12.50
    -25.60
    -24.70
    0.00
    102.00
    Depreciation
    166.80
    9.45
    34.30
    0.37
    495.92
    Tax
    80.90
    79.78
    -5.05
    -2.47
    305.90
    Net Profit
    149.40
    21.07
    -27.58
    -1655.60
    594.60
    EPS (₹)
    1.25
    20.19
    -28.16
    -6.90
    36.67

    Biocon Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    398.05
    -2.33
    -2.49
    -3.92
    15.90
    73.90
    133.76
    417.69
    935.50
    -2.30
    0.81
    8.64
    9.82
    23.30
    -0.57
    -45.68
    384.55
    -2.58
    -2.90
    7.90
    18.80
    66.94
    -20.30
    -4.42
    2838.90
    2.00
    -0.30
    17.20
    10.13
    61.07
    66.43
    0.00
    4508.00
    -1.91
    -2.02
    15.43
    19.47
    75.17
    124.15
    5.45
    760.60
    -2.24
    5.32
    19.05
    33.40
    56.99
    40.49
    7.48
    937.60
    -0.76
    8.94
    14.24
    35.71
    56.57
    32.99
    26.00
    1081.85
    0.07
    7.68
    14.92
    34.67
    98.27
    110.07
    61.04
    2827.45
    -1.50
    -1.04
    20.16
    15.63
    68.85
    132.51
    85.78
    2018.95
    0.65
    2.97
    21.31
    30.63
    109.60
    393.09
    162.51
    3065.05
    -2.12
    14.89
    39.12
    29.68
    84.09
    388.69
    181.22
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Biocon Ltd Risk Return Comparison

    with peersNew

    Biocon Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Biocon Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    11.15
    7.55
    -97.73
    37.52
    Return on Assets (%)
    5.55
    5.64
    -34.68
    37.98
    Return on capital Employed (%)
    8.25
    10.19
    -13.51
    32.77
    Fixed Assets Turnover (x)
    0.72
    0.31
    -36.70
    2.51
    Profitability and Growth
    Gross Profit Margin (%)
    16.50
    9.91
    -29.80
    43.32
    Operating Profit Margin(%)
    25.17
    15.61
    -10.13
    46.18
    Net Profit margin (%)
    11.75
    5.24
    -98.56
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    0.68
    2.09
    0.29
    37.52
    Current Ratio (x)
    1.03
    2.88
    0.34
    37.52
    Cash ratio (x)
    0.19
    0.26
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.18
    0.23
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    1.36
    2.74
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Biocon Ltd Share Holding as on 30-06-2020

    CategoryNo. of sharesPercentage
    Promoters477,025,59639.75
    ForeignInstitutions191,171,58515.93
    NBanksMutualFunds56,227,2934.69
    Others54,451,6564.54
    GeneralPublic126,561,34710.55
    FinancialInstitutions29,952,7972.50
    ForeignPromoter250,990,08020.92
    GDR13,619,6461.13

    MF Ownership Of Biocon Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    ICICI Pru Balanced Advantage Direct-G
    Portfolio as on 31-07-2020
    Hybrid: Dynamic Asset Allocation
    5520108
    -5.84%
    0.87%
    226.10
    ICICI Pru Bluechip Direct-G
    Portfolio as on 31-07-2020
    Equity: Large Cap
    4206892
    -20.48%
    0.71%
    172.31
    Kotak Equity Arbitrage Direct-G
    Portfolio as on 31-07-2020
    Hybrid: Arbitrage
    2208000
    10.09%
    0.59%
    90.44
    Nippon India Arbitrage Direct-G
    Portfolio as on 31-07-2020
    Hybrid: Arbitrage
    1584700
    -7.64%
    0.86%
    64.91
    Nippon India Growth Direct-G
    Portfolio as on 31-07-2020
    Equity: Mid Cap
    1542325
    -25.58%
    0.97%
    63.17

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Biocon Ltd.

    Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 47880.00 Crore) operating in Pharmaceuticals sector.

    Biocon Ltd. key Products/Revenue Segments include Other Operating Revenue which contributed Rs 229.40 Crore to Sales Value (7.95 % of Total Sales), Waste which contributed Rs 15.10 Crore to Sales Value (0.52 % of Total Sales) and Sale of services which contributed Rs 1.00 Crore to Sales Value (0.03 % of Total Sales)for the year ending 31-Mar-2019.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 1671.30 Crore, up 5.71 % from last quarter Sales of Rs 1581.00 Crore and up 14.01 % from last year same quarter Sales of Rs 1465.90 Crore Company has reported net profit after tax of Rs 171.40 Crore in latest quarter.

    The company’s top management includes Dr.Vijay Kuchroo, Mr.Siddharth Mittal, Mr.Russel Walls, Mr.Mary Harney, Mr.M Damodaran, Mr.Kiran Mazumdar Shaw, Mr.John Shaw, Mr.Daniel M Bradbury, Mr.Bobby Kanubhai Parikh, Prof.Ravi Mazumdar. Company has B S R & Co. LLP as its auditors As on 30-06-2020, the company has a total of 1,200,000,000 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors